Mentions of artificial intelligence within the filings of companies in the medical devices industry fell 21% between the first and second quarters of 2022.
In total, the frequency of sentences related to artificial intelligence between July 2021 and June 2022 was 210% higher than in 2016 when GlobalData, from whom our data for this article is taken, first began to track the key issues referred to in company filings.
When companies in the medical devices industry publish annual and quarterly reports, ESG reports and other filings, GlobalData analyses the text and identifies individual sentences that relate to disruptive forces facing companies in the coming years.
